Scholars Central

Conference abstractPublished 8 Aug 2016

The role of cyclic AMP-ERK-c-Jun pathways on L-DOPA-induced neurotoxicity in neuronal and PC12 cells and the in vivo applications

Authors: Myung Koo Lee

Chungbuk National University, Republic of Korea

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Parkinson’s disease (PD) causes by the degeneration of dopamine neurons in the substantia nigra. L-3,4-Dihydroxyphenylalanine (L-DOPA) is the most frequently prescribed drug for controlling the symptoms of PD. However, the high levels of L-DOPA lead to cell death by generating reactive oxygen species in dopamine neurons and PC12 cells. The intracellular levels of cyclic AMP (cAMP) increase in response to cytotoxic concentrations of L-DOPA in PC12 cells, and multiple treatments with non-toxic L-DOPA (MT-LD) reduce dopamine biosynthesis in PC12 cells. We therfore investigated the effects of L-DOPA on ERK1/2 and JNK1/2-c-Jun systems. MT-LD (10 and 20 µM) induced cell survival via PKA-transient ERK1/2 activation in PC12 cells. MT-LD also induced differentiation via the Epac-sustained ERK1/2-c-Jun system, which subsequently led to the activation of the cell death process. In addition, SE and GP-EX enhanced dopamine biosynthesis and L-DOPA-induced increase in dopamine levels by inducing TH activity and TH gene expression in PC12 cells. SE and GP-EX protected L-DOPA-induced cytotoxicity through the modulation of the oxidative stress-induced cell death signaling pathways in PC12 cells. SE and GP-EX also showed the prophylactic and adjuvant therapeutic effects on long-term L-DOPA therapy in 6-hydroxydopamine-lesioned rat model of PD, suggesting that SE and GP-EX might serve as an adjuvant phytonutrient for PD. Taken together, it has been proposed that chronic treatment of L-DOPA led to the neurotoxic process via the cAMP-sustained ERK-c-Jun system and the modulation of ERK activity might be applied for screening the anti-neurodegenerative agents.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • SubjectNeuroscience & Neurology
  • BylineArticles whose byline prints “Myung Koo Lee”